Lorazepam and Akathisia - a phase IV clinical study of FDA data
Akathisia is found among people who take Lorazepam, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Lorazepam and have Akathisia. It is created by eHealthMe based on reports of 141,245 people who have side effects when taking Lorazepam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
141,245 people reported to have side effects when taking Lorazepam.
Among them, 498 people (0.35%) have Akathisia.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 145,096 Lorazepam users for its effectiveness, alternative drugs and more.
What is Akathisia?
Akathisia (a movement disorder characterized by a feeling of inner restlessness) is found to be associated with 1,309 drugs and 790 conditions by eHealthMe.
Number of Lorazepam and Akathisia reports submitted per year:
Time on Lorazepam when people have Akathisia *:
Gender of people who have Akathisia when taking Lorazepam*:
Age of people who have Akathisia when taking Lorazepam *:
Common drugs people take besides Lorazepam *:
Common side effects people have besides Akathisia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lorazepam and have Akathisia?Check whether Akathisia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
How severe was Akathisia and when was it recovered:
Expand to all the drugs that have ingredients of lorazepam:
- Akathisia and drugs with ingredients of lorazepam (466 reports)
Alternative drugs to, pros and cons of Lorazepam:
- Lorazepam (145,096 reports)
Common Lorazepam side effects:
- Fatigue (feeling of tiredness): 10,549 reports
- Drug ineffective: 8,056 reports
- Stress and anxiety: 7,584 reports
- Diarrhea: 7,459 reports
- Breathing difficulty: 7,375 reports
- Pain: 6,805 reports
- Weakness: 6,627 reports
- Nausea and vomiting: 6,515 reports
Browse all side effects of Lorazepam:a b c d e f g h i j k l m n o p q r s t u v w x y z
Akathisia treatments and more:
- Akathisia (13,580 reports)
COVID vaccines that are related to Akathisia:
- Akathisia in Moderna COVID Vaccine
- Akathisia in Pfizer BioNTech Covid Vaccine
- Akathisia in Johnson and Johnson Covid Vaccine
Common drugs associated with Akathisia:
- Abilify: 2,045 reports
- Metoclopramide: 1,929 reports
- Clopra: 1,929 reports
- Olanzapine: 971 reports
- Risperidone: 958 reports
- Risperdal: 898 reports
- Aripiprazole: 842 reports
- Zyprexa: 651 reports
- Rexulti: 638 reports
- Reglan: 598 reports
All the drugs that are associated with Akathisia:
- Akathisia (1,309 drugs)
Common conditions associated with Akathisia:
- Schizophrenia: 1,496 reports
- Depression: 1,250 reports
- Bipolar disorder: 934 reports
- Major depression: 562 reports
- Stress and anxiety: 554 reports
- Schizoaffective disorder: 275 reports
- Insomnia: 269 reports
All the conditions that are associated with Akathisia:
- Akathisia (790 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zofran and Non-Hodgkin'S Lymphoma - a second ago
- Detrol La and Hair Color Changes - 8 seconds ago
- Ibu and Acetaminophen And Codeine Phosphate drug interaction - 16 seconds ago
- Morphine and Oralone drug interaction - 25 seconds ago
- Levothroid and Hyperventilation - 34 seconds ago
- Alavert and Proteinuria Aggravated - 39 seconds ago
- Zaroxolyn and Arthritis Bacterial - 39 seconds ago
- Neulasta and Bell'S Palsy - 40 seconds ago
- Dulcolax and Vivelle drug interaction - 52 seconds ago
- Vitamin B2 and Impaired Gastric Emptying - 56 seconds ago